GlaxoSmithKline Pharmaceuticals appoints Manu Anand to its Board

Manu Anand

GlaxoSmithKline Pharmaceuticals Limited announced the appointment of Manu Anand as Additional Director on the Board of the company, with effect from May 16, 2022.

According to the company’s exchange filing, “Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that Board of Directors of the Company at its meeting held today has appointed as Mr. Manu Anand (DIN:00396716) an Additional Independent Director of the Company for a term of five years w.e.f. from 16th May 2022.”

Manu Anand, age 63, is a Chartered Accountant and has completed Advance Management Program from the Warton School of the University of Pennsylvania, USA. Manu brings the experience of over three decades, out of which he has been in the general manager roles for the last 20 years with a track record of building diverse teams, driving growth, managing multi-billion dollar P&Ls, and leading change and transformation.

In his role with Mondelez International before his retirement, he managed the Chocolate business (approx.$2 billion) operations across the Asia Pacific, Middle East, and Africa, covering a range of developed and developing markets. The role required managing the levers of P&L, driving top and bottom line and market share growth through a combination of region-wide and market-specific initiatives on the brands and innovation. In addition, he ran a consolidated supply chain with a complex manufacturing site network and worked closely with sales teams in markets to deliver sustained business performance. Manu was earlier leading the India business for Mondelez International and as Managing Director for Cadbury India Limited was responsible for all business functions; the role required a high degree of general management skills to steer the categories and functions appropriately to drive continued growth and build competent teams. Mondelez International started transforming to a category run model from the end of 2014, and he led significant change management initiatives to transition the organization to the new model seamlessly.

At PepsiCo India, Manu spent 19 years in various roles and is credited with building its food business virtually from scratch. In his last role at PepsiCo as the Chairman and CEO, PepsiCo India Manu was responsible for PepsiCo’s beverage and foods business (including JVs) in India and South Asia, reporting to the President of AMEA. PepsiCo India was a scale operation with over 6000 direct employees, over 50 manufacturing sites, and availability in over 2 million retail outlets with high growth driven by scale brands. Preceding this, Manu was based in Bangkok as the President of South-East Asia. He was responsible for the Beverage and Food businesses in Thailand, Vietnam, Malaysia, Indonesia, Singapore, Cambodia, and Laos. The Business Unit was a complex portfolio of different business models in the various stages of development across the markets. It included Company-owned businesses, Joint Ventures, and Franchise business models through bottlers. The job helped develop a strong ability to collaborate and work effectively with local partners while learning to work effectively in a multi-cultural environmental.

As a result, Manu successfully built sustainability and profitable growth models in these competitive, high potential markets with healthy growth in top and bottom lines. Currently Manu is the Senior Advisor with Advent and Director on Manjushree Technopack and DFM Foods boards. He has also been a member of Confederation of Indian Industry (CII) and has experience as Chairman of PepsiCo India and Director on board of Mondelez India.

+ posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: